These results demonstrate that STOML2 promotes cell proliferation and aerobic glycolysis in MM through regulation of PAI-1 expression, providing a new mechanism of MM progression and a novel therapeutic target for drug discovery. This evidence concerns the gene SERPINE1 and Miyoshi myopathy.